132MO Molecular profiling of 991 prospectively recruited rare cancers patients in EUROPE: First results of ARCAGEN – an EORTC-SPECTA and EURACAN study — Marie Morfouace (2023) | RDL Network
Ángela Lamarca, Marie Morfouace, Sabine Tejpar, Julliete Cristina de Oliveira, Andreia Capela, Nicolas Penel, Christine Gennigens, Birutė Brasiūnienė, Julien Péron, Aleksandra Stevovic, Jean Yves Blay, H-J Klümpen
Marie Morfouace, Aleksandra Stevovic, Marie Vinches, Vassilis Golfinopoulos, Dexter X. Jin, Oliver Holmes, Rachel Erlich, Jérôme Fayette, Sabrina Croce, Isabelle Ray‐Coquard, Nicolas Girard, Jean Yves Blay
Marco Tagliamento, Marie Morfouace, Charalambos Loizides, Júlio Oliveira, Laurent Greillier, Judith Raimbourg, Anne‐Claire Toffart, Thierry Chatellier, Nicolas Cloarec, Ivana Sullivan, Birutė Brasiūnienė, M. Duruisseaux, Kersti Oselin, Marie-Sophie Robert, C. Fernandes, Arnaud Poncin, Jean Yves Blay, Benjamin Besse, Nicolas Girard
Marie Morfouace, Aleksandra Stevovic, Júlio Oliveira, Nicolas Penel, Julien Péron, Paolo G. Casali, Michael J. Seckl, Jourik A. Gietema, Wouter W. de Herder, Lucjan Wyrwicz, Christelle de la FOUCHARDIERE, Lisa Licitra, Nicolas Girard, Sophie Piperno‐Neumann, Ellen Kapiteijn, Ahmed IDBAIH, Jean Yves Blay
M. Tagliamento, M. Morfouace, C. Loizides, João Douglas Ribeiro Oliveira, L. Greiller, J. Raimbourg, A.C. Toffart, T. Chatelier, N. Cloarec, I.G. Sullivan, B. Brasiuniene, J. Peron, K. Oselin, M-S. Robert, C. Fernandes, Arnaud Poncin, Jean Yves Blay, B. Besse, N. Girard
Discussion(0)
No comments yet. Be the first to comment.